David Pernock
2020 - Eagle Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $245,600 |
|---|---|
| Option Awards | $1,604,636 |
| Salary | $606,530 |
| Stock Awards | $1,285,485 |
| Other | $44,189 |
| Total | $3,786,440 |
Pernock received $1.6M in option awards, accounting for 42% of the total pay in 2020.
Pernock also received $245.6K in non-equity incentive plan, $606.5K in salary, $1.3M in stock awards and $44.2K in other compensation.
Rankings
In 2020, David Pernock's compensation ranked 3,038th out of 13,090 executives tracked by ExecPay. In other words, Pernock earned more than 76.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,038 out of 13,090 | 77th |
Division Manufacturing | 1,186 out of 5,618 | 79th |
Major group Chemicals And Allied Products | 451 out of 2,251 | 80th |
Industry group Drugs | 390 out of 1,951 | 80th |
Industry Pharmaceutical Preparations | 291 out of 1,456 | 80th |
Pay ratio
| David Pernock's Pay | $3,786,440 |
|---|---|
| Median Employee's Pay | $254,007 |
| Pay Ratio | 15to 1 |
In 2020, the annual total compensation of David Pernock was $3,786,440.
The annual total compensation of the median employee at Eagle Pharmaceuticals was $254,007.
The ratio of David Pernock's pay to the pay of median employee was therefore 15 to one.
Pernock's colleagues
We found five more compensation records of executives who worked with David Pernock at Eagle Pharmaceuticals in 2020.
2020
Scott Tarriff
Eagle Pharmaceuticals
Chief Executive Officer
2020
Pete Meyers
Eagle Pharmaceuticals
Chief Financial Officer
2020
Adrian Hepner
Eagle Pharmaceuticals
Chief Medical Officer
2020
Brian Cahill
Eagle Pharmaceuticals
Chief Financial Officer
2020
Judith Ng-Cashin
Eagle Pharmaceuticals
Chief Medical Officer
News
June 15, 2022
April 30, 2021
April 29, 2020
April 30, 2019